31. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases. Issue 2 (May 2018) Authors: Erler, Darby; Brotherston, Drew; Sahgal, Arjun; Cheung, Patrick; Loblaw, Andrew; Chu, William; Soliman, Hany; Chung, Hans; Kiss, Alex; Chow, Edward; Poon, Ian Journal: Radiotherapy and oncology Issue: Volume 127:Issue 2(2018) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?. (October 2018) Authors: Merino Lara, Tomas; Helou, Joelle; Poon, Ian; Sahgal, Arjun; Chung, Hans T.; Chu, William; Soliman, Hany; Ung, Yee; Verma, Sunil; Cheema, Parneet; Cheng, Susanna; Khanna, Suneil; Erler, Darby; Zhang, Liying; Cheung, Patrick Journal: Lung cancer Issue: Volume 124(2018) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomized trial. Issue 2 (May 2018) Authors: Quon, Harvey C.; Ong, Aldrich; Cheung, Patrick; Chu, William; Chung, Hans T.; Vesprini, Danny; Chowdhury, Amit; Panjwani, Dilip; Pang, Geordi; Korol, Renee; Davidson, Melanie; Ravi, Ananth; McCurdy, Boyd; Zhang, Liying; Mamedov, Alexandre; Deabreu, Andrea; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 127:Issue 2(2018) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters. (August 2021) Authors: Tan, Hendrick; Cheung, Patrick; Louie, Alexander V.; Myrehaug, Sten; Niglas, Mark; Atenafu, Eshetu G.; Chu, William; Chung, Hans T.; Poon, Ian; Sahgal, Arjun; Soliman, Hany Journal: Radiotherapy and oncology Issue: Volume 161(2021) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter. (January 2020) Authors: Thompson, Robert; Cheung, Patrick; Chu, William; Myrehaug, Sten; Poon, Ian; Sahgal, Arjun; Soliman, Hany; Tseng, Chia-Lin; Wong, Shun; Ung, Yee; Beatriz Kinupe Abrahão, Ana; Erler, Darby; Zhang, Liying; Ko, Yoo-Joung; Chung, Hans T. Journal: Radiotherapy and oncology Issue: Volume 142(2020) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Issue 1 (January 2017) Authors: Morton, Gerard; Chung, Hans T.; McGuffin, Merrylee; Helou, Joelle; D'Alimonte, Laura; Ravi, Ananth; Cheung, Patrick; Szumacher, Ewa; Liu, Stanley; Al-Hanaqta, Motasem; Zhang, Liying; Mamedov, Alexandre; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 122:Issue 1(2017:Jan.) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. (May 2020) Authors: Morton, Gerard; McGuffin, Merrylee; Chung, Hans T.; Tseng, Chia-Lin; Helou, Joelle; Ravi, Ananth; Cheung, Patrick; Szumacher, Ewa; Liu, Stanley; Chu, William; Zhang, Liying; Mamedov, Alexandre; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 146(2020) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: Late toxicity and patient reported outcomes from a randomized phase II clinical trial. (March 2021) Authors: Corkum, Mark; Loblaw, Andrew; Hasan, Yaser; Chung, Hans T.; Tseng, Chia-Lin; McGuffin, Merrylee; Cheung, Patrick; Szumacher, Ewa; Liu, Stanley; Chu, William; Zhang, Liying; Mamedov, Alexandre; Morton, Gerard Journal: Radiotherapy and oncology Issue: Volume 156(2021) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost. (January 2021) Authors: Alayed, Yasir; Loblaw, Andrew; McGuffin, Merrylee; Chung, Hans T.; Tseng, Chia-Lin; D'Alimonte, Laura; Cheung, Patrick; Liu, Stanley; Chu, William; Szumacher, Ewa; Helou, Joelle; Ravi, Ananth; Haider, Masoom; Mamedov, Alexandre; Zhang, Liying; Morton, Gerard Journal: Radiotherapy and oncology Issue: Volume 154(2021) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?. Issue 3 (June 2017) Authors: Helou, Joelle; D'Alimonte, Laura; Quon, Harvey; Deabreu, Andrea; Commisso, Kristina; Cheung, Patrick; Chu, William; Mamedov, Alexandre; Davidson, Melanie; Ravi, Ananth; Loblaw, Andrew Journal: Radiotherapy and oncology Issue: Volume 123:Issue 3(2017:Jun.) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗